对于ST段升高心肌梗塞的 Excimer LASER冠状动脉切除术:来自多中心注册表的见解
Yuji Matsuda1, Taishi Yonetsu1, Ken Kurihara2
1Department of Cardiovascular Medicine, Institute of Science Tokyo Hospital, Tokyo, Japan.
Journal of cardiology
|January 22, 2025
概括
排泄激光冠状动脉除术 (ELCA) 在ST段升高心肌梗塞 (STEMI) 患者中没有减少心脏不良事件. 更大的ELCA导管可能会提供更好的结果,这表明需要在STEMI治疗方面进行进一步研究.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 急性冠状动脉综合征是什么
背景情况:
- 排泄激光冠状动脉除术 (ELCA) 用于ST段升高心肌梗塞 (STEMI) 中的血栓性病变.
- 在STEMI患者中ELCA的临床有效性仍然不完全理解.
研究的目的:
- 评估ELCA在接受初级皮肤冠状动脉干预的STEMI患者中的有效性.
- 为了比较使用ELCA和不使用ELCA治疗的患者之间的临床结果.
主要方法:
- 在症状发作后24小时内对连续的STEMI患者进行回顾性分析.
- 患者被分为ELCA和非ELCA组.
- 与目标血管相关的重大心脏不良事件 (TV-MACE) 是主要终点,使用考克斯回归和倾向得分匹配进行分析.
主要成果:
- 在总体队列 (2593名患者) 中,ELCA和非ELCA组之间的TV-MACE无生存没有显著差异.
- 使用ELCA并不是TV-MACE的显著预测因素 (HR 1.265,p=0.161).
- 在倾向得分匹配队列 (736名患者) 中,无TV-MACE生存率在各组之间保持相似.
结论:
- 在STEMI患者中,ELCA的使用与心脏不良事件的减少无关.
- 对大尺寸的ELCA导管 (1.4-1.7毫米) 观察到更好的结果趋势,这表明了潜在的好处.
- 需要进一步的前性研究来证实大型ELCA导管在STEMI中的有效性.
更多相关视频
12:00Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
15.5K
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
1.4K
相关概念视频
01:17Ischemic Heart Disease: Overview
3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
01:30Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741